Open Access

Poster session 3 - Acute Heart Failure (AHF)

Event: ESC CONGRESS 2017
Topic: Miscellaneous
Session type: Poster Session
Date: 27 August 2017

Session

17 presentations in this session

Automated ECG quantification of myocardial scar in patients with and without conduction defects: correlation with myocardial perfusion imaging and clinical outcome in acute heart failure patients

Speaker: Doctor P. Badertscher (Basel, CH)
Thumbnail

The recovery of pulsatile hemodynamics during hospitalization in patients with heart failure with reduced, mid-range and preserved ejection fraction

Speaker: Assistant Professor W. Huang (Taipei, TW)
Thumbnail

The prognostic implication of the diuretic and natriuretic responses to the combined administration of loop diuretics and tolvaptan in patients with acute decompensated heart failure

Speaker: Doctor T. Sakaguchi (Osaka, JP)
Thumbnail

Furosemide versus bumetanide; a deep dive into national heart failure audit (England & Wales)

Speaker: Doctor A. shoaib (Stoke on Trent, GB)
Thumbnail

Incidence and in-hospital case fatality of acute decompensated heart failure in chile: a stratified analysis by gender

Speaker: Assistant Professor F. Diaz (Santiago, CL)
Thumbnail

Prediction of 30-day heart failure readmission and death with early post-discharge ST2 and NTproBNP

Speaker: Doctor M. Domingo (Badalona, ES)
Thumbnail

Prognostic value of in-hospital variation of red blood cell distribution (RDW) in acute phases of cardiac failure.

Thumbnail

Risk and predictors of readmission for heart failure following a myocardial infarction between 2004-2013: A Swedish nationwide observational study

Speaker: Doctor L. Desta (Stockholm, SE)
Thumbnail

Prognosis of patients hospitalized for heart failure in Spain according to medical admission department

Speaker: Doctor A. Esteban Fernandez (Leganes, ES)
Thumbnail

Impact on clinical events and healthcare costs of adding telemedicine to multidisciplinary care of patients with heart failure and mid-range or preserved LVEF: a randomised controlled trial

Speaker: Doctor S. Jimenez-Marrero (Barcelona, ES)
Thumbnail

16 speakers from this session

Doctor Patrick Badertscher

University Hospital Basel, Basel (Switzerland)
0 follower

Assistant Professor Wei Ming Huang

Taipei Veterans General Hospital, Taipei (Taiwan)
0 follower

Doctor Taiki Sakaguchi

Osaka National Hospital, Osaka (Japan)
0 follower

Doctor Ahmad shoaib

Royal Stoke University Hospital, Stoke on Trent (United Kingdom of Great Britain & Northern Ireland)
0 follower

Assistant Professor Felipe Diaz

Catholic University Clinical Hospital, Santiago (Chile)
0 follower

Doctor Mar Domingo

University Hospital Germans Trias and Pujol de Badalona, Badalona (Spain)
0 follower

Doctor Liyew Awoke Desta

Karolinska Institute, Danderyd Hospital, Department of Cardiology, Stockholm (Sweden)
0 follower

Doctor Alberto Esteban Fernandez

Severo Ochoa Hospital, Leganes (Spain)
0 follower

Doctor Santiago Jimenez-Marrero

University Hospital of Bellvitge, Barcelona (Spain)
0 follower

Doctor Igor Gorda

Kiev Alexander Clinical Hospital, Kiev (Ukraine)
0 follower

Doctor Vladislav Titov

Federal Almazov Medical Research Centre, Saint Petersburg (Russian Federation)
0 follower

Doctor Joanna Wisniewska

National Institute of Cardiology, Warsaw (Poland)
0 follower

Doctor Constantinos Ergatoudes

University of Gothenburg, Gothenburg (Sweden)
0 follower

Doctor David Corcoran

Queen Elizabeth University Hospital, Glasgow (United Kingdom of Great Britain & Northern Ireland)
0 follower

Associate Professor Anzhela Soloveva

Almazov National Medical Reseach Centre, Saint Petersburg (Russian Federation)
0 follower

Doctor Federica Dellafiore

IRCCS, Policlinico San Donato, San Donato Milanese (Italy)
0 follower

This platform is supported by

logo Novo Nordisk